Comparison of Circulating Maternal Placenta Growth Factor Levels and Sonographic Evaluation of Patients with Abnormal First Trimester Screening Analytes.
Eran AshwalJohannes KeunenAnjana RavichandranKatie EllulSwati AgrawalSebastian R HobsonRory C WindrimJohn C KingdomPublished in: Prenatal diagnosis (2023)
In pregnancies with unexplained abnormal first-trimester biomarkers, mid-trimester PlGF outperformed a comprehensive ultrasound assessment in the identification of a subset of patients destined to develop placental dysfunction. This blood test may be an alternative initial approach in this context, especially where access to specialist care is more geographically-challenging. This article is protected by copyright. All rights reserved.
Keyphrases
- growth factor
- palliative care
- end stage renal disease
- pregnancy outcomes
- healthcare
- magnetic resonance imaging
- preterm birth
- ejection fraction
- chronic kidney disease
- gestational age
- prognostic factors
- quality improvement
- birth weight
- pregnant women
- pain management
- physical activity
- chronic pain
- ultrasound guided
- patient reported
- weight loss
- contrast enhanced ultrasound